Price, one year
Price range
- Open
- ₹2,282.90
- High
- ₹2,289.60
- Low
- ₹2,224.90
- Previous close
- ₹2,275.60
- Volume
- 1.2 L
- Market cap
- ₹92,031 Cr
Key statistics
Results to 30 Jun 2026 · Consolidated- P/E (TTM)
- 46.0
- Price to book
- 5.8
- Return on equity
- 12.6%
- EPS (TTM)
- ₹49.49
- Book value / share
- ₹394.64
- Debt to equity
- 0.38
- Revenue (TTM)
- ₹14,738 Cr
- Net profit (TTM)
- ₹2,049 Cr
- Sales growth, YoY
- +12.9%
- Profit growth, YoY
- +31.0%
- Operating margin
- 26.0%
- Net margin
- 13.9%
- Sales CAGR, 3 years
- +17.7%
- Profit CAGR, 3 years
- +14.3%
- Promoter holding
- 72.62%
- Promoter shares pledged
- 0.00%
Shareholding pattern
% of shares| Holder | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|
| Promoters | 72.66 | 72.63 | 72.62 |
| Foreign institutions | 10.24 | 9.45 | 9.37 |
| Domestic institutions | 14.46 | 15.39 | 15.56 |
| Mutual funds | 10.36 | 10.87 | 11.31 |
| Retail and others | 1.39 | 1.29 | 1.26 |
Futures and options
22 Oct 2026- Lot size
- 250
- Put-call ratio (OI)
- 0.49
- Max pain
- ₹2,340.00
- Highest call OI strike
- 2,600.00
- Highest put OI strike
- 2,300.00
- ATM implied volatility
- 29.4% IV rank 35
- Futures basis
- +0.35%
- Rollover
- 27.7%
Futures open interest, last sessions
| Date | Build-up | Price | OI change |
|---|---|---|---|
| 22 Oct | Short covering | +0.40% | −1.32% |
| 21 Oct | Short covering | +0.56% | −2.17% |
| 19 Oct | Short buildup | −0.95% | +1.17% |
| 16 Oct | Short buildup | −3.05% | +2.77% |
| 15 Oct | Short covering | +0.90% | −0.54% |
Option figures are for the 27 Oct 2026 expiry.
Results and announcements
Latest results (quarter to 30 Jun 2026) filed 30 Jul 2026. results: 26 Oct 2026.
Peers in Healthcare
All Healthcare stocks| Company | Price | Change |
|---|---|---|
| Sun Pharmaceutical IndustriesSUNPHARMA | ₹1,740.40 | −1.00% |
| Divi's LaboratoriesDIVISLAB | ₹8,881.00 | −3.07% |
| Torrent PharmaceuticalsTORNTPHARM | ₹4,487.80 | −2.76% |
| Zydus LifesciencesZYDUSLIFE | ₹1,124.80 | −0.90% |
| Apollo Hospitals EnterpriseAPOLLOHOSP | ₹7,584.50 | −0.26% |
| CiplaCIPLA | ₹1,319.30 | −0.87% |
| Laurus LabsLAURUSLABS | ₹1,943.10 | −2.97% |
| Dr. Reddy's LaboratoriesDRREDDY | ₹1,226.70 | −0.99% |
| Aurobindo PharmaAUROPHARMA | ₹1,557.50 | −3.31% |
| LupinLUPIN | ₹1,906.60 | −0.80% |
Frequently asked questions
What is the share price of Mankind Pharma today?
Mankind Pharma (NSE: MANKIND) was at ₹2,228.10 on 23 Oct 2026, a change of −2.09% from the previous close.
What are the 52-week high and low of Mankind Pharma?
Over the last 52 weeks Mankind Pharma traded between ₹1,909.70 and ₹2,642.00 (daily highs and lows on NSE on 23 Oct 2026).
What is the market capitalisation of Mankind Pharma?
About ₹92,031 Cr at the latest price, with a P/E of 46.0, a price-to-book of 5.8, a return on equity of 12.6%. Ratios use the company's latest reported results.
Who owns Mankind Pharma shares?
According to the shareholding pattern filed with the exchange at the end of the quarter to 30 Sep 2026, promoters held 72.62%, foreign institutions 9.37%, domestic institutions 15.56%.
Is Mankind Pharma traded in futures and options?
Yes, MANKIND is in NSE's futures and options segment. The lot size is 250 shares.
Which sector and indices does Mankind Pharma belong to?
NSE classifies Mankind Pharma under Healthcare; it is a member of Nifty 500.
Follow Mankind Pharma with research you can verify. Add it to a watchlist, see screens and charts, and get calls from SEBI-registered research analysts with recorded track records.
Get started free